Clozapine REMS Deadline Closing In


The Clozapine Risk Evaluation and Mitigation Strategy (REMS) Program is starting tomorrow. Prescribers, patients, and pharmacies are getting a new start in this system. Here are the relevant links:

See the site

Get an overview

Get the facts

Take the test


I doubt anyone is going to be in trouble if they’re not ready on October 12, 2105. Heck, even my department has not yet sent out an announcement. I happen to know that our pharmacists and at least one psychiatrist are gearing up for the Clozapine REMS Program. I have to say, I’ll miss the times when all I had to do was call the pharmacist.

My paperwork is ready to fax to 844-404-8876…glory days are over.

2 thoughts on “Clozapine REMS Deadline Closing In

  1. Jim,

    What am I missing here?

    I thought the current non-REMs clozapine program was established as being incredibly safe.

    Is this just a case of FDA branding?

    George Dawson, MD


    1. I don’t know, George. I’ve got all I can do just to keep up. I’m about to genuinely thumb my nose at the ABPN MOC program altogether. What with the FDA branding thing on clozapine (you could be right), consultation crises going through the roof, and Governor Branstad taking away inpatient psychiatric beds just when demand for them skyrockets, I’ve got enough real work to manage without dealing with MOC busywork too…retirement is looking better every day.

      Liked by 1 person

Comments are closed.